http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-782540-L
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1cd6051bf69f25a0652ded4e4edac31 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 |
filingDate | 1978-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1979-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | IE-782540-L |
titleOfInvention | Tablets containing¹1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane |
abstract | The tablet is designed to be swallowed and to disintegrate in the presence of the gastrointestinal fluids. It comprises 5 to 80 % by weight of 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane or one of its pharmaceutically acceptable salts and 20 to 95 % by weight of a mixture of an alkali metal carbonate or bicarbonate or alkaline earth metal carbonate or bicarbonate and citric acid. The tablet has an equilibrium relative moisture content of less than 25 %. These tablets are suitable for the treatment of gastrointestinal disorders.n[GB1595220A] |
priorityDate | 1977-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.